Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
Clinical trial NCT01764269 · COMPLETED
Trial details
- NCT number
- NCT01764269
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-04-01
- Enrollment
- 656
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.